Blue Jet Healthcare Limited (NSE: BLUEJET)
India
· Delayed Price · Currency is INR 509.45
+30.75 (6.42%)
Sep 6, 2024, 3:29 PM IST
Blue Jet Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Revenue | 6,950 | 7,116 | 7,210 | 6,835 | 4,989 | 5,382 |
| Revenue Growth (YoY) | -8.08% | -1.30% | 5.49% | 36.99% | -7.30% | - |
| Cost of Revenue | 3,090 | 3,144 | 3,427 | 2,946 | 1,695 | 2,104 |
| Gross Profit | 3,860 | 3,972 | 3,783 | 3,889 | 3,295 | 3,278 |
| Selling, General & Admin | 552.29 | 531.85 | 418.97 | 330.3 | 289.55 | 238.75 |
| Other Operating Expenses | 1,162 | 1,148 | 1,173 | 1,066 | 944.67 | 851.89 |
| Operating Expenses | 1,970 | 1,961 | 1,843 | 1,614 | 1,431 | 1,271 |
| Operating Income | 1,890 | 2,011 | 1,940 | 2,275 | 1,864 | 2,007 |
| Interest Expense | -1.4 | -1.61 | -13.59 | -32.82 | -46.91 | -64.19 |
| Interest & Investment Income | - | - | 5.87 | 4.38 | 6.16 | 6.13 |
| Currency Exchange Gain (Loss) | - | - | 147.66 | 167.53 | 46.22 | 38.32 |
| Other Non Operating Income (Expenses) | 325.12 | 288.6 | 13.89 | 2.38 | -5.06 | -1.54 |
| EBT Excluding Unusual Items | 2,214 | 2,298 | 2,094 | 2,417 | 1,864 | 1,985 |
| Gain (Loss) on Sale of Investments | - | - | 71.11 | 19.36 | 34.28 | -44.23 |
| Gain (Loss) on Sale of Assets | - | - | 1.03 | 0.29 | 1.04 | - |
| Asset Writedown | - | - | - | -3.85 | - | - |
| Other Unusual Items | -97.43 | -97.43 | - | - | -53.07 | - |
| Pretax Income | 2,116 | 2,201 | 2,166 | 2,432 | 1,847 | 1,941 |
| Income Tax Expense | 542.36 | 563.44 | 565.84 | 616.39 | 488.7 | 491.68 |
| Earnings From Continuing Operations | 1,574 | 1,638 | 1,600 | 1,816 | 1,358 | 1,450 |
| Minority Interest in Earnings | - | - | - | - | 26.28 | -1.11 |
| Net Income | 1,574 | 1,638 | 1,600 | 1,816 | 1,384 | 1,448 |
| Net Income to Common | 1,574 | 1,638 | 1,600 | 1,816 | 1,384 | 1,448 |
| Net Income Growth | -10.72% | 2.33% | -11.88% | 31.19% | -4.44% | - |
| Shares Outstanding (Basic) | 173 | 173 | 173 | 173 | 173 | 173 |
| Shares Outstanding (Diluted) | 173 | 173 | 173 | 173 | 173 | 173 |
| Shares Change (YoY) | -0.06% | -0.00% | - | - | - | - |
| EPS (Basic) | 9.08 | 9.44 | 9.23 | 10.47 | 7.98 | 8.35 |
| EPS (Diluted) | 9.08 | 9.44 | 9.23 | 10.47 | 7.98 | 8.35 |
| EPS Growth | -10.63% | 2.33% | -11.88% | 31.19% | -4.44% | - |
| Free Cash Flow | - | 683.96 | 822.85 | 1,246 | 971.62 | 1,067 |
| Free Cash Flow Per Share | - | 3.94 | 4.74 | 7.18 | 5.60 | 6.15 |
| Dividend Per Share | 1.000 | 1.000 | - | - | - | - |
| Gross Margin | 55.54% | 55.82% | 52.47% | 56.89% | 66.04% | 60.90% |
| Operating Margin | 27.20% | 28.27% | 26.91% | 33.29% | 37.36% | 37.29% |
| Profit Margin | 22.65% | 23.01% | 22.20% | 26.57% | 27.74% | 26.91% |
| Free Cash Flow Margin | - | 9.61% | 11.41% | 18.24% | 19.47% | 19.83% |
| EBITDA | 2,185 | 2,292 | 2,148 | 2,484 | 2,059 | 2,186 |
| EBITDA Margin | 31.44% | 32.21% | 29.80% | 36.35% | 41.28% | 40.62% |
| D&A For EBITDA | 294.64 | 280.91 | 208.11 | 209.35 | 195.52 | 179.56 |
| EBIT | 1,890 | 2,011 | 1,940 | 2,275 | 1,864 | 2,007 |
| EBIT Margin | 27.20% | 28.27% | 26.91% | 33.29% | 37.36% | 37.29% |
| Effective Tax Rate | 25.63% | 25.60% | 26.12% | 25.34% | 26.47% | 25.33% |
| Revenue as Reported | 7,275 | 7,405 | 7,449 | 7,029 | 5,078 | 5,440 |
Source: S&P Capital IQ. Standard template. Financial Sources.